carbon monoxide has been researched along with Bronchiectasis in 14 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Bronchiectasis: Persistent abnormal dilatation of the bronchi.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The levels of exhaled nitric oxide (eNO), carbon monoxide (eCO) and nasal NO (nNO) from bronchiectatic patients with PCD (n=14) were compared with those from patients with non-PCD bronchiectasis without (n=31) and with cystic fibrosis (CF) (n=20) and from normal subjects (n=37) to assess the clinical usefulness of these measurements in discriminating between PCD and other causes of bronchiectasis." | 7.72 | Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. ( Barnes, PJ; Cole, PJ; Csiszér, E; Horváth, I; Kharitonov, SA; Loukides, S; Wodehouse, T, 2003) |
| "Bronchiectasis is a chronic inflammatory lung disease associated with increased production of oxidants due mostly to neutrophilic inflammation." | 5.30 | Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. ( Barnes, PJ; Cole, PJ; Horvath, I; Kharitonov, SA; Loukides, S; Wodehouse, T, 1998) |
| "The levels of exhaled nitric oxide (eNO), carbon monoxide (eCO) and nasal NO (nNO) from bronchiectatic patients with PCD (n=14) were compared with those from patients with non-PCD bronchiectasis without (n=31) and with cystic fibrosis (CF) (n=20) and from normal subjects (n=37) to assess the clinical usefulness of these measurements in discriminating between PCD and other causes of bronchiectasis." | 3.72 | Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. ( Barnes, PJ; Cole, PJ; Csiszér, E; Horváth, I; Kharitonov, SA; Loukides, S; Wodehouse, T, 2003) |
| "(2) There is a valid definition for COPD." | 2.49 | A challenge to the seven widely believed concepts of COPD. ( Al-Kassimi, FA; Alhamad, EH, 2013) |
| "Unclassifiable-interstitial lung disease (uILD) represents a heterogeneous collection of pathologies encompassing those fibrosing lung diseases which do not fulfill current diagnostic criteria." | 1.46 | Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices. ( Bartholmai, BJ; Brun, AL; Egashira, R; Hansell, DM; Jacob, J; Karwoski, R; Kokosi, M; Nair, A; Nicholson, AG; Rajagopalan, S; Walsh, SLF; Wells, AU, 2017) |
| "Diffuse bronchiectasis was the main finding." | 1.43 | Preclinical lung disease in early rheumatoid arthritis. ( Dorca, J; Luburich, P; Molina-Molina, M; Narvaez-Garcia, J; Nolla, JM; Robles-Perez, A; Rodriguez-Sanchon, B, 2016) |
| "Among the most common are interstitial lung disease (ILD) and bronchiectasis." | 1.35 | Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. ( Abdul Manap, R; Azhar Shah, S; Mohd Noor, N; Mohd Shahrir, MS; Shahid, MS; Shahizon Azura, AM, 2009) |
| "Bronchiectasis is a chronic inflammatory lung disease associated with increased production of oxidants due mostly to neutrophilic inflammation." | 1.30 | Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. ( Barnes, PJ; Cole, PJ; Horvath, I; Kharitonov, SA; Loukides, S; Wodehouse, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, K | 1 |
| Zou, X | 1 |
| Ma, Z | 1 |
| Liu, X | 1 |
| Qiu, C | 1 |
| Xie, L | 1 |
| Lin, Z | 1 |
| Li, S | 1 |
| Wu, Y | 1 |
| Raji, H | 1 |
| Riahi, A | 1 |
| Borsi, SH | 1 |
| Masoumi, K | 1 |
| Khanjani, N | 1 |
| AhmadiAngali, K | 1 |
| Goudarzi, G | 1 |
| Dastoorpoor, M | 1 |
| Carpagnano, GE | 1 |
| Santacroce, R | 1 |
| Palmiotti, GA | 1 |
| Leccese, A | 1 |
| Giuffreda, E | 1 |
| Margaglione, M | 1 |
| Foschino Barbaro, MP | 1 |
| Aliberti, S | 1 |
| Lacedonia, D | 1 |
| Jacob, J | 1 |
| Bartholmai, BJ | 1 |
| Rajagopalan, S | 1 |
| Egashira, R | 1 |
| Brun, AL | 1 |
| Kokosi, M | 1 |
| Nair, A | 1 |
| Walsh, SLF | 1 |
| Karwoski, R | 1 |
| Nicholson, AG | 1 |
| Hansell, DM | 1 |
| Wells, AU | 1 |
| Nyilas, S | 1 |
| Schreder, T | 1 |
| Singer, F | 1 |
| Poellinger, A | 1 |
| Geiser, TK | 1 |
| Latzin, P | 1 |
| Funke, M | 1 |
| Robles-Perez, A | 1 |
| Luburich, P | 1 |
| Rodriguez-Sanchon, B | 1 |
| Dorca, J | 1 |
| Nolla, JM | 1 |
| Molina-Molina, M | 1 |
| Narvaez-Garcia, J | 1 |
| Garcia-Olive, I | 1 |
| Radua, J | 1 |
| Fiz, JA | 1 |
| Sanz-Santos, J | 1 |
| Ruiz-Manzano, J | 1 |
| Mohd Noor, N | 1 |
| Mohd Shahrir, MS | 1 |
| Shahid, MS | 1 |
| Abdul Manap, R | 1 |
| Shahizon Azura, AM | 1 |
| Azhar Shah, S | 1 |
| Martinet, Y | 1 |
| Wirth, N | 1 |
| Al-Kassimi, FA | 1 |
| Alhamad, EH | 1 |
| Horváth, I | 2 |
| Loukides, S | 2 |
| Wodehouse, T | 2 |
| Csiszér, E | 1 |
| Cole, PJ | 2 |
| Kharitonov, SA | 2 |
| Barnes, PJ | 2 |
| WOOLF, CR | 1 |
| Emad, A | 1 |
| Rezaian, GR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis (HYBRID): A Randomized, Multi-center, Double-blind, Parallel-group Study[NCT02765295] | 120 participants (Anticipated) | Interventional | 2016-06-01 | Recruiting | |||
| Efficacy and Safety of Lung Dispersing, Turbid Descending and Gut Clearing Decoction on Clinically Stable Bronchiectasis (LUNG-CLEAR): A Multicenter, Randomized, Cross-over Trial[NCT03177889] | 80 participants (Anticipated) | Interventional | 2021-12-31 | Not yet recruiting | |||
| Guangzhou Institute of Respiratory Disease[NCT02315547] | 120 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carbon monoxide and Bronchiectasis
| Article | Year |
|---|---|
A challenge to the seven widely believed concepts of COPD.
Topics: Asthma; Basement Membrane; Biopsy; Bronchi; Bronchiectasis; Bronchoscopy; Carbon Monoxide; Diagnosis | 2013 |
13 other studies available for carbon monoxide and Bronchiectasis
| Article | Year |
|---|---|
Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.
Topics: Bronchiectasis; Carbon Monoxide; Fibrosis; Humans; Lung Diseases, Interstitial; Pulmonary Diffusing | 2022 |
Acute Effects of Air Pollution on Hospital Admissions for Asthma, COPD, and Bronchiectasis in Ahvaz, Iran.
Topics: Age Factors; Air Pollutants; Air Pollution; Asthma; Bronchiectasis; Carbon Monoxide; Hospitalization | 2020 |
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Bronchiectasis; Carbon Monoxide; Female; Forced | 2017 |
Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
Topics: Aged; Bronchiectasis; Carbon Monoxide; Connective Tissue Diseases; Female; Forced Expiratory Volume; | 2017 |
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Breath Tests; Bronchiectasis; Carbon Monoxide; Female; Humans; Idiopathic Pulmonary Fib | 2018 |
Preclinical lung disease in early rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bronchiectasis; Carbon Monoxide; Female; Humans; Lung; Lung Diseases; Prospec | 2016 |
Association between Air Pollution and Hemoptysis.
Topics: Adult; Aged; Air Pollution; Bronchial Arteries; Bronchiectasis; Carbon Monoxide; Embolization, Thera | 2016 |
Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Asian People; Bronchiectasis; Carbon Monoxide | 2009 |
[About interpretation of exhaled CO in smoking cessation].
Topics: Asthma; Bronchiectasis; Carbon Monoxide; Carboxyhemoglobin; Exhalation; Female; Humans; Male; Pulmon | 2010 |
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.
Topics: Adult; Breath Tests; Bronchiectasis; Carbon Monoxide; Ciliary Motility Disorders; Female; Forced Exp | 2003 |
THE RELATIONSHIPS BETWEEN MINUTE VENTILATION, PULMONARY GAS DIFFUSION AND RESPIRATORY WORK MEASURED SIMULTANEOUSLY DURING A STANDARD EXERCISE TEST.
Topics: Bronchial Diseases; Bronchiectasis; Bronchitis; Carbon Monoxide; Cystic Fibrosis; Eosinophilic Granu | 1965 |
The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases.
Topics: Adult; Aged; Airway Obstruction; Asthma; Biopsy; Bronchiectasis; Bronchitis; Bronchoscopy; Carbon Mo | 1997 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Topics: Androstadienes; Anti-Inflammatory Agents; Biomarkers; Breath Tests; Bronchiectasis; Carbon Monoxide; | 1998 |